Capital One Financial started coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating) in a research note released on Friday, The Fly reports. The firm issued an overweight rating and a $16.00 target price on the stock. A number of other equities analysts have also recently weighed in on OLMA. Lifesci Capital reissued an […]
Capital One Financial assumed coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating) in a research report released on Friday morning, The Fly reports. The firm issued an overweight rating and a $16.00 target price on the stock. Several other brokerages also recently issued reports on OLMA. Credit Suisse Group reduced their price objective […]